cro.directory
← Compare landing

Allucent vs Certara

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAllucentCertara
SummaryAllucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies.Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Biomarker Assays
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (General)
  • Discovery
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (IND-Enabling)
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
LocationsData not yet provided.
  • Global network
  • Global presence, 30 countries
  • Global presence, Multiple, 30 countries, Global
  • Global presence, Multiple, 30+ countries
  • Global presence, Multiple, 30 countries, International
  • Headquarters, Radnor, Pennsylvania, United States
  • Global presence, 30 countries
  • Global presence, 30+ countries
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Allucent alternatives · Certara alternatives

Markdown mirror: /compare/allucent/certara.md